Archive: 13/11/2015

Merck continuing study of cholesterol drug in new class

Merck & Co. said Friday that it will continue a huge patient study of an experimental cholesterol medicine, the last one standing in a once-promising class of drugs being developed to prevent heart attacks, after an independent ...

page 1 from 7